dsm-firmenich AG stock (CH1216478797): dual listing on SIX Swiss Exchange and ongoing buyback in focus

dsm-firmenich AG shares were in focus on 06/02/2026 after the Swiss-based nutrition and beauty group reported further progress on its share repurchase program and celebrated the start of trading on SIX Swiss Exchange alongside its primary Euronext Amsterdam listing.

dsm-firmenich AG shares attracted attention on 06/02/2026 after the Swiss group reported weekly progress in its ongoing share repurchase program and highlighted that its stock has begun trading on SIX Swiss Exchange, complementing the existing Euronext Amsterdam listing, according to a company press release published the same day via GlobeNewswire as of 06/02/2026.

Headquartered in Kaiseraugst in Switzerland, the company underlines its home-country positioning by adding a domestic listing on SIX Swiss Exchange while maintaining its main line on Euronext Amsterdam under the ticker DSFIR, giving investors in the Netherlands and Switzerland direct access to the stock in their local markets, as referenced by SIX Group in a May 2026 overview of new listings on the Swiss exchange.

The latest weekly update shows that dsm-firmenich continued buying back its own shares under the program designed to cover share-based plans and reduce capital, with purchases completed in the final week of May 2026 as disclosed in the 06/02/2026 release via GlobeNewswire.

The buyback adds to a series of capital management actions following the combination of DSM and Firmenich, which created a large player in nutrition, health, and beauty; the current program allows the group to mitigate dilution from employee share plans while gradually shrinking the free float, according to the company.

On its primary Euronext Amsterdam venue, financial data providers such as MarketScreener cited a recent closing price for DSFIR around the low-70s euro area in late May 2026, situating the stock roughly in the middle of its broader 12-month trading range as of that period.

For Swiss investors, the start of trading on SIX Swiss Exchange in May 2026 means dsm-firmenich is now part of the domestic universe tracked by the Swiss stock exchange, as confirmed in SIX Group market statistics for that month.

In Germany, the shares are also available via secondary trading venues such as Tradegate, typically quoted in euros and reflecting the underlying Euronext Amsterdam price with intraday spreads.

As of: 06/02/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: DSM-Firmenich
• Sector/industry: Nutrition, health and beauty ingredients
• Headquarters/country: Kaiseraugst, Switzerland
• Core markets: Europe, North America, Asia-Pacific
• Key revenue drivers: Nutritional ingredients, flavors and fragrances, health and wellness solutions
• Home exchange/listing venue: Euronext Amsterdam (DSFIR), SIX Swiss Exchange (DSFIR)
• Trading currency: EUR

dsm-firmenich AG: core business model

The group focuses on developing and supplying specialty nutrition, taste, and fragrance solutions, with sales largely driven by long-term partnerships with food, personal care, and health-product manufacturers.

Latest quarterly results for dsm-firmenich AG at a glance

For its most recently reported quarter, Q4 2024, dsm-firmenich published results earlier in 2025 showing that it delivered adjusted earnings per share of about USD 0.99 compared with analyst expectations closer to USD 0.96, while quarterly revenue came in around USD 3.26 billion versus consensus of slightly above that level, according to financial data compiled by Investing.com as of early 2025.

Those Q4 2024 figures, released through the company's investor relations materials and reflected in external earnings summaries, indicate that profitability slightly outpaced market forecasts even though revenue remained fractionally below some analyst models, against the backdrop of integration efforts following the DSM and Firmenich merger.

Conclusion

The latest weekly disclosure on dsm-firmenich's share repurchase program and the confirmation of trading on SIX Swiss Exchange place capital allocation and market access at the center of the investment debate.

Alongside the Q4 2024 earnings profile, which showed earnings slightly ahead of expectations on broadly in-line revenue, the current setup underscores how management is balancing integration of the combined business with shareholder-focused measures.

How these elements interact with broader demand trends in nutrition, health, and beauty ingredients will remain a key factor for the share price trajectory on Euronext Amsterdam, SIX Swiss Exchange, and secondary venues.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.